Author: admin

Podium Presentations

2012

  • Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the United KingdomISPOR 15th Annual European Congress, Berlin, Germany, 5-7 November, 2012 (Podium presentation slides)
Posters

2011

  • Zaniolo O, Bettoncelli G, Bosio G, Mantovani LG, Pistelli R, Vaghi A, Villa M, Iannazzo S, Bamfi F, Pitrelli A, Frizzo V, Dal Negro RW. How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost? ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Didoni G, Crocchiolo D. A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy. ISPOR 14th Annual European Congress, Madrid, Spain November, 2011
  • Paggiaro P, Buseghin G, Nicolini G, Patel S, Iannazzo S, Zaniolo O, Papi A. The Cost-Effectiveness of Step Down From High Dose ICS/LABA Combination Therapy in Asthma in the UK Setting. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Pradelli L, Montagnoli R, Militano L. Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients With Hyperglycaemia in Italy. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Pradelli L, Chiroli S, Pétavy F, Briggs A. A Simulation Model of the Effects of Treatments for Secondary Hyperparathyroidism on Mortality. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
Papers

2011

  • ReadSacchi V. Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+. Farmeconomia e percorsi terapeutici 2011; 12(2): 77-85
  • ReadZaniolo O, Iannazzo S, Patrucco GP, Bellini R. Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice. Farmeconomia e percorsi terapeutici 2011; 12(2): 87-94
  • ReadZaniolo O, Carsi M, Iannazzo S. Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation. Farmeconomia e percorsi terapeutici 2011; 12(2): 45-52
  • ReadZaniolo O, Bettoncelli G, Bosio G, Mantovani L, Pistelli R, Vaghi A, Villa M, Iannazzo S, Bamfi F, Frizzo V, Dal Negro RW. Estimation of economic consequences of GOLD guidelines adoption in the Italian clinical practice. Farmeconomia e percorsi terapeutici 2011; 12(1): 5-19
  • ReadDal Negro RW, Pradelli L, Tognella S, Micheletto C, Iannazzo S. Cost-utility of add-on omalizumab in difficult-to-treat allergic asthma in Italy. Eur Ann Allergy Clin Immunol 2011; 43(2): 45-53
  • ReadIannazzo S, Pradelli L, Carsi M, Perachino M. Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy. Value Health 2011; 14(1): 80-9
  • ReadIannazzo S. Pharmacoeconomic evaluation of the MF59–adjuvanted influenza vaccine in the elderly population in Italy. J Prev Med Hyg 2011; 52(1):1-8
Podium Presentations

2011

  • BTS Winter Meeting 2011. London, England, December, 2011
  • Fundamentals of Health Economics Models – First in Class Drugs, How to Evaluate Their Cost Effectiveness: Real Life Examples for Calcimimetics. 1st Annual Pharmacoeconomics Middle East Forum, Abu Dhabi, UAE, 3rd March, 2011
Papers

2010

  • ReadCapri S, Benucci M, Iannazzo S, Zaniolo O, D’Arpino A. Un modello di Budget Impact per la valutazione economica di tocilizumab come prima linea biologica nei pazienti con artrite reumatoide di grado moderato o severo. Italian Journal of Public Health – Year 8, Volume 7, Number 2, Suppl 2, 2010: S44-53
  • ReadEandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy. Pharmacoeconomics 2010; 28(11): 1041-54
  • ReadBenucci M, Iannazzo S, Zaniolo O, Sabadini L. Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis. Clin Exp Rheumatol 2010; 28(5): 722-7
  • ReadPradelli L, Iannazzo S, Zaniolo O, Botrugno P. Organization and Estimated Patient-Borne Costs of Oral Anticoagulation Therapy in Italy: Results from a Survey. Appl Health Econ Health Policy 2010; 8 (2): 119-128
  • ReadZaniolo O, Wolowacz SE, Pradelli L. Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy. Farmeconomia e percorsi terapeutici 2010; 11(2): 91-101
  • ReadSacchi V, Zaniolo O, Olivieri I. Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept. Farmeconomia e percorsi terapeutici 2010; 11(2): 63-76
  • ReadZaniolo O, Sacchi V, Dal Negro RW. Tiotropium in COPD: clinical outcomes and economic evidence. Farmeconomia e percorsi terapeutici 2010; 11(1): 27-41
Podium Presentations

2010

  • Valutazione farmacoeconomica dell’uso di tiotropio bromide nel trattamento di lungo termine dei pazienti con BPCO in Italia. 15° Convegno Annuale AIES, Turin, Italy, 1st October, 2010
  • Amgen Advisory Board: Relationship Between Vascular Calcification and Clinical and Health Economics Outcomes in Dialysis Patients. Zurich, Switzerland, 18th June, 2010
  • L’importanza dell’adiuvante MF59 nei vaccini influenzali: aggiornamento su sicurezza, efficacia clinica e dati di farmacoeconomia. Congress SItI, Turin, Italy, 25th May, 2010 and Naples, Italy, 8th June, 2010
  • Nuove prospettive nelle manifestazioni del dolore cronico, nuovi utilizzi di ziconotide. Bologna, Italy, 21-22th January, 2010
Posters

2010

  • Zaniolo O, Pradelli L. Economic Performance of Dabigatran Etexilate for Primary VTE Prevention Following Total Hip and Knee Replacement Surgery in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Pradelli L, Chiroli S. A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism (SHPT) in Five European Countries. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Zaniolo O, Giuliani G. A Budget Impact Model for the Economic Assessment of Tocilizumab in the Treatment of Rheumatoid Arthritis Patients in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Zaniolo O, Iannazzo S, Carsi M. A Cost-Utility Analysis for Tiotropium in the Long Term Treatment of Specific Subgroups of Italian COPD Patients. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Pradelli L, Zaniolo O, Iannazzo S, Eandi M. Parenteral Alanyl-Glutammine in Critically Ill Patients: a Bayesian Meta-Analysis of Published Trials. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Zaniolo O, Carsi M, Patrucco GP, Bellini R. Clinical and Economic Outcomes of Ziconotide Neuromodulation in Italian Cancer Patients. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Zaniolo O, Carsi M. Pharmacoeconomic Evaluation of Tiotropium Bromide in the Long Term Treatment of COPD in Italy. ECHE, 8th European Conference on Health Economics, Helsinki, Finland, 7-10 July, 2010 (Poster n. 137)
  • Iannazzo S, Pradelli L, Chiroli S, Pontoriero G, Eandi M. A Cost-Utility Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism (SHPT): Consistent Results in Three European Countries. XLVII ERA-EDTA CONGRESS, Munich, Germany, 25-28 June, 2010,
Papers

2009

  • ReadPradelli L, Iannazzo S, Zaniolo O. The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model. Am J Cardiovasc Drugs 2009; 9: 383-392
  • ReadSacchi V, Pradelli L. Effectiveness and cost of treatment with maraviroc in HIV infection. Farmeconomia e percorsi terapeutici 2009; 10(4): 149-159
  • ReadZaniolo O. Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery. Farmeconomia e percorsi terapeutici 2009; 10(3): 115-128
  • ReadSacchi V, Iannazzo S, Giunta F. Sugammadex in antagonism of neuromuscular block in anesthesia: a clinical and economic profile. Farmeconomia e percorsi terapeutici 2009; 10(3): 103-114
  • ReadMuscaritoli M, Pradelli L, Zaniolo O, Iannazzo S, Eandi M. The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy. Farmeconomia e percorsi terapeutici 2009; 10(2): 83-92
  • ReadZaniolo O. Costs of diabetes in Italy. Farmeconomia e percorsi terapeutici 2009; 10(2): 73-81
  • ReadIannazzo S, Sacchi V. Pharmacoeconomic evaluation of influenza vaccination programs in elderly in Italy. Farmeconomia e percorsi terapeutici 2009; 10(2): 59-72
  • ReadPradelli L, Iannazzo S. Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation. Journal of Medical Economics 2009; 12(1): 25-35
  • ReadBamfi F, Basso F, Aglietta M, Bengala C, Lorusso V, Pronzato P, Cavallo MC, Zaniolo O, Iannazzo S. Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy. Farmeconomia e percorsi terapeutici 2009; 10(1): 33-46
  • ReadBenucci M, Iannazzo S, Sabadini L. Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy. Farmeconomia e percorsi terapeutici 2009; 10(1): 19-31
  • ReadZaniolo O, Pradelli L. Budget impact analysis of use of aliskiren in hypertension on the Italian Health Care System. Farmeconomia e percorsi terapeutici 2009; 10(1): 5-18
Posters

2009

  • Eandi M, Pradelli L, Iannazzo S. Alanyl-Glutamine Dipeptide (Dipeptiven®) in Total Parenteral Nutrition (TPN) Therapy in Critically Ill Italian Patients: a Pharmacoeconomic Simulation Model. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Pradelli L, Perachino M. Cost-Effectiveness Analysis of Hormonal Therapies in Patients With Advanced Prostate Cancer in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Sacchi V. A Pharmacoeconomic Evaluation of Influenza Vaccination in the Elderly Population in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S , Zaniolo O, Botrugno P. Survey on the Management of Oral Anticoagulation Therapy (Oat) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Dal Negro RW, Pradelli L, Micheletto C, Tognella S, Iannazzo S. Add-on Omalizumab in Persistent Difficult-to-Treat Asthma: a 12-Month Study on Clinical, Economic Outcomes and Related Cost/Utility. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Eandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. A Patient-Level Simulation Model for Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism (SHPT) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009